Nereid Therapeutics
PrivateLast Round
Series A
Nov 16, 2020
Total Funding Raised
$50M
Company Overview
Nereid Therapeutics is a biotechnology company that develops small molecule therapeutics for cancer, neurodegenerative disorders, and inflammatory diseases by leveraging proprietary technologies to study liquid-liquid phase separation and biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nereid Therapeutics Comparables
Compare Nereid Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transition Bio | 92% | |
| Dewpoint Therapeutics | 91% | |
| Aquinnah Pharmaceuticals | 88% |
Nereid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 16, 2020 |
Nereid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 16, 2020
$50M round led by Apple Tree Partners
Nereid Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nereid Therapeutics's valuation, stock price, and market status.
Is Nereid a public or private company?
Nereid is a private company.
What is the current stock price of Nereid?
Nereid is a private company with no public stock price. No recent secondary market data is available.
How much is Nereid worth (valuation)?
Valuation information for Nereid is not publicly available.
Can I buy Nereid stock?
Nereid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nereid's last funding round?
Nereid's most recent funding round was Series A on November 16, 2020.
Who are the main investors in Nereid?
Key investors in Nereid include Apple Tree Partners.
Will Nereid IPO soon?
No public IPO plans have been announced for Nereid.
How can I track Nereid secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nereid's secondary market activity and sign up for updates.